FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Ewer

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Hearts

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Co-author Network

Publications

TOP 3
Michael S Ewer; Ming Yang; Aman U Buzdar
Screening for cardiac risk before anthracycline administration: what are the real benefits?
Michael S Ewer; Daniel Von Hoff; Robert S Benjamin
A historical perspective of anthracycline cardiotoxicity.
Frank R Tortorella; Ronald Walters; Pamela B Douglas-Ntagha; Michael S Ewer; Gayle Harper; Wenonah B Ecung
Developing a transfer center in a tertiary cancer center: streamlining access and communication to accommodate increasing demand for service.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Ewer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Michael S Ewer; Ming Yang; Aman U Buzdar
Screening for cardiac risk before anthracycline administration: what are the real benefits?
Clinical breast cancer 2012;12(1):1-3.
2011: Michael S Ewer; Daniel Von Hoff; Robert S Benjamin
A historical perspective of anthracycline cardiotoxicity.
Heart failure clinics 2011;7(3):363-72.
2011: Frank R Tortorella; Ronald Walters; Pamela B Douglas-Ntagha; Michael S Ewer; Gayle Harper; Wenonah B Ecung
Developing a transfer center in a tertiary cancer center: streamlining access and communication to accommodate increasing demand for service.
Journal of healthcare management / American College of Healthcare Executives 2011;56(3):199-210; discussion 210-1.
2010: Michael S Ewer; Steven M Ewer
Cardiotoxicity of anticancer treatments: what the cardiologist needs to know.
Nature reviews. Cardiology 2010;7(10):564-75.
2010: Michael S Ewer; Steven M Ewer
Troponin I provides insight into cardiotoxicity and the anthracycline-trastuzumab interaction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(25):3901-4.
2009: Michael S Ewer; Steven M Ewer
Long-term cardiac safety of dose-dense anthracycline therapy cannot be predicted from early ejection fraction data.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(36):6073-5.
2009: Michael S Ewer; Stefan Gluck
A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health.
Cancer 2009;115(9):1813-26.
2009: Steven M Ewer; Michael S Ewer
Anthracycline cardiotoxicity: why are we still interested?
Oncology (Williston Park, N.Y.) 2009;23(3):234-5, 239.
2008: Michael S Ewer; Daniel J Lenihan; Aarif Y Khakoo
Sunitinib-related cardiotoxicity: an interdisciplinary issue.
Nature clinical practice. Cardiovascular medicine 2008;5(7):364-5.
2008: Edith A Perez; Maria Koehler; Julie Byrne; Alaknanda J Preston; Erica Rappold; Michael S Ewer
Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials.
Mayo Clinic proceedings. Mayo Clinic 2008;83(6):679-86.
2008: Michael S Ewer; Daniel J Lenihan
Is trastuzumab associated with adverse cardiac effects in patients with breast cancer?
Nature clinical practice. Oncology 2008;5(4):192-3.
2008: Michael S Ewer; Daniel J Lenihan
Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1201-3.
2008: Steven M Ewer; Michael S Ewer
Cardiotoxicity profile of trastuzumab.
Drug safety : an international journal of medical toxicology and drug experience 2008;31(6):459-67.
2007: Michael S Ewer; Joyce A O'Shaughnessy
Cardiac toxicity of trastuzumab-related regimens in HER2-overexpressing breast cancer.
Clinical breast cancer 2007;7(8):600-7.
2007: Atiar M Rahman; Yusuf Syed Wamique; Michael S Ewer
Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.
International journal of nanomedicine 2007;2(4):567-83.
2007: Aman U Buzdar; Vicente Valero; Nuhad K Ibrahim; Deborah Francis; Kristine Broglio; Richard L Theriault; Lajos Pusztai; Marjorie C Green; S Eva Singletary; Kelly K Hunt; Aysegul A Sahin; Francisco J Esteva; W Fraser Symmans; Michael S Ewer; Thomas Buchholz; Gabriel N Hortobagyi
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(1):228-33.
2005: Michael S Ewer; Mary T Vooletich; Jean-Bernard Durand; Myrshia L Woods; Joseph R Davis; Vicente Valero; Daniel J Lenihan
Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7820-6.
2005: Aman U Buzdar; Nuhad K Ibrahim; Deborah Francis; Daniel J Booser; Eva S Thomas; Richard L Theriault; Lajos Pusztai; Marjorie C Green; Banu Arun; Sharon H Giordano; Massimo Cristofanilli; Debra Frye; Terry L Smith; Kelly K Hunt; S Eva Singletary; Aysegul A Sahin; Michael S Ewer; Thomas Buchholz; Donald Berry; Gabriel N Hortobagyi
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3676-85.
2005: Michael S Ewer; Scott M Lippman
Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):2900-2.
2004: Michael S Ewer; Francis J Martin; Craig Henderson; Charles L Shapiro; Robert S Benjamin; Alberto Gabizon
Cardiac safety of liposomal anthracyclines.
Seminars in oncology 2004;31(6 Suppl 13):161-81.
2004: Edward T H Yeh; Ann T Tong; Daniel J Lenihan; Yusuf Syed Wamique; Joseph Swafford; Christopher Champion; Jean-Bernard Durand; Harry Gibbs; Alireza Atef Zafarmand; Michael S Ewer
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
Circulation 2004;109(25):3122-31.
2002: Sharon H Giordano; Daniel J Booser; James L Murray; Nuhad K Ibrahim; Zia Rahman; Vicente Valero; Richard L Theriault; Marguerite F Rosales; Edgardo Rivera; Debra Frye; Michael S Ewer; Nelson G Ordonez; Aman U Buzdar; Gabriel N Hortobagyi
A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3360-8.
2002: Susannah K Wallace; Michael S Ewer; Kristen J Price; Thomas W Feeley
Outcome and cost implications of cardiopulmonary resuscitation in the medical intensive care unit of a comprehensive cancer center.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2002;10(5):425-9.
2001: Michael S Ewer; Susannah K Kish; Charles G Martin; Kristen J Price; Thomas W Feeley
Characteristics of cardiac arrest in cancer patients as a predictor of survival after cardiopulmonary resuscitation.
Cancer 2001;92(7):1905-12.
2001: Su Gülsün Berrak; Michael S Ewer; Norman Jaffe; Peggy Pearson; HL Ried; Hallie Zietz; Robert S Benjamin
Doxorubicin cardiotoxicity in children: reduced incidence of cardiac dysfunction associated with continuous-infusion schedules.
Oncology reports 2001;8(3):611-4.
1999: Michael S Ewer; H R Gibbs; Joseph Swafford; Robert S Benjamin
Cardiotoxicity in patients receiving transtuzumab (Herceptin): primary toxicity, synergistic or sequential stress, or surveillance artifact?
Seminars in oncology 1999;26(4 Suppl 12):96-101.
1999: Vicente Valero; Aman U Buzdar; Richard L Theriault; Nozar Azarnia; G A Fonseca; Jie Willey; Michael S Ewer; Ronald S Walters; B Mackay; Donald A Podoloff; Daniel J Booser; L W Lee; Gabriel N Hortobagyi
Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluorouracil as first-line therapy in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1425-34.
1999: Nuhad K Ibrahim; Gabriel N Hortobagyi; Michael S Ewer; M K Ali; Lina Asmar; Richard L Theriault; Giuseppe Fraschini; Debra Frye; Aman U Buzdar
Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience.
Cancer chemotherapy and pharmacology 1999;43(6):471-8.
1998: Michael S Ewer; Norman Jaffe; HL Ried; Hallie Zietz; Robert S Benjamin
Doxorubicin cardiotoxicity in children: comparison of a consecutive divided daily dose administration schedule with single dose (rapid) infusion administration.
Medical and pediatric oncology 1998;31(6):512-5.
1995: Paolo Anderlini; Robert S Benjamin; Franklin C Wong; Hagop M Kantarjian; Michael Andreeff; Steven M Kornblau; Susan O'Brien; B Mackay; Michael S Ewer; S A Pierce
Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(11):2827-34.
1995: Michael S Ewer; J K Taubert
Advance directives in the intensive care unit of a tertiary cancer center.
Cancer 1995;76(7):1268-74.
1995: RG Kilbourn; G A Fonseca; Owen W Griffith; Michael S Ewer; K Price; A Striegel; E Jones; C J Logothetis
NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.
Critical care medicine 1995;23(6):1018-24.
1994: M K Ali; Michael S Ewer; H R Gibbs; J Swafford; K L Graff
Late doxorubicin-associated cardiotoxicity in children. The possible role of intercurrent viral infection.
Cancer 1994;74(1):182-8.
1994: Bruce Mackay; Michael S Ewer; C H Carrasco; R S Benjamin
Assessment of anthracycline cardiomyopathy by endomyocardial biopsy.
Ultrastructural pathology 1994;18(1-2):203-11.
1994: Michael S Ewer; M K Ali; H R Gibbs; J Swafford; K L Graff; A Cangir; N Jaffe; M K Thapar
Cardiac diastolic function in pediatric patients receiving doxorubicin.
Acta oncologica (Stockholm, Sweden) 1994;33(6):645-9.
1992: H R Gibbs; J Swafford; Michael S Ewer; M K Ali
Cardiac emergencies in the cancer patient.
Oncology (Williston Park, N.Y.) 1992;6(10):25-9; discussion 29-32.
1992: Michael S Ewer; M K Ali; H R Gibbs; J Swafford
Nodus migrans: the case of the migrating knot.
American journal of critical care : an official publication, American Association of Critical-Care Nurses 1992;1(2):108-10.
1992: H R Gibbs; J Swafford; H D Nguyen; Michael S Ewer; M K Ali
Postoperative atrial fibrillation in cancer surgery: preoperative risks and clinical outcome.
Journal of surgical oncology 1992;50(4):224-7.
1991: Dong M Shin; A M Kramer; I W Dimery; Martin N Raber; Michael S Ewer; Waun Ki Hong
Phase II clinical trial of 4'-O-tetrahydropyranyl-adriamycin (THP-adriamycin) in recurrent squamous cell carcinoma of the head and neck.
Investigational new drugs 1991;9(1):89-91.
1990: R Wallerstein; G Spitzer; Frank Dunphy; SD Huan; Gabriel N Hortobagyi; JC Yau; Aman U Buzdar; Frankie A Holmes; Richard L Theriault; Michael S Ewer
A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(11):1782-8.
1990: Michael S Ewer; M K Ali
Surgical treatment of the cancer patient: preoperative assessment and perioperative medical management.
Journal of surgical oncology 1990;44(3):185-90.
1989: T Umsawasdi; Manuel Valdivieso; Daniel J Booser; H T Barkley; Michael S Ewer; Bruce Mackay; H M Dhingra; WK Murphy; G Spitzer; D F Chiuten
Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer.
Cancer 1989;64(10):1995-2000.
1989: Michael S Ewer
Philosophy of care, decision making, and ethical considerations.
Critical care clinics 1989;5(3):679-95.
1989: E Edmund Kim; Sidney Wallace; R Abello; J D Coan; Michael S Ewer; P A Salem; M K Ali
Malignant cardiac fibrous histiocytomas and angiosarcomas: MR features.
Journal of computer assisted tomography 1989;13(4):627-32.
1989: Gabriel N Hortobagyi; H Y Yap; S W Kau; Giuseppe Fraschini; Michael S Ewer; S P Chawla; Robert S Benjamin
A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancer.
American journal of clinical oncology 1989;12(1):57-62.
1989: Gabriel N Hortobagyi; Debra Frye; Aman U Buzdar; Michael S Ewer; Giuseppe Fraschini; V Hug; Frederick C Ames; E Montague; C H Carrasco; Bruce Mackay
Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma.
Cancer 1989;63(1):37-45.
1988: Michael S Ewer; M K Ali
Critical cardiologic considerations in the cancer patient.
Critical care clinics 1988;4(1):41-60.
1987: M K Ali; Michael S Ewer; P V Balakrishnan; D A Ochoa; Rodolfo C Morice; A E Raizner; G M Lawrie
Balloon angioplasty for superior vena cava obstruction.
Annals of internal medicine 1987;107(6):856-7.
1987: M K Ali; Michael S Ewer; A Cangir; D J Fisher
Coronary artery embolism following cancer chemotherapy.
The American journal of pediatric hematology/oncology 1987;9(3):200-3.
1986: Michael S Ewer; M K Ali; M S Atta; Rodolfo C Morice; P V Balakrishnan
Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure.
JAMA : the journal of the American Medical Association 1986;256(24):3364-6.
1985: R J McKenna; M K Ali; Michael S Ewer; O H Frazier
Pleural and pericardial effusions in cancer patients.
Current problems in cancer 1985;9(6):1-44.
1985: R S Benjamin; S P Chawla; Michael S Ewer; C H Carrasco; B Mackay; F Holmes
Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update.
Investigational new drugs 1985;3(2):117-21.
1984: Manuel Valdivieso; M A Burgess; Michael S Ewer; B Mackay; S Wallace; R S Benjamin; M K Ali; Gerald P Bodey; E J Freireich
Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(3):207-14.
1984: Michael S Ewer; M K Ali; B Mackay; S Wallace; Manuel Valdivieso; Sewa S Legha; R S Benjamin; T P Haynie
A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(2):112-7.
1983: M K Ali; Michael S Ewer; M R Atallah; C F Mountain; C L Dixon; D A Johnston; T P Haynie
Regional and overall pulmonary function changes in lung cancer. Correlations with tumor stage, extent of pulmonary resection, and patient survival.
The Journal of thoracic and cardiovascular surgery 1983;86(1):1-8.
1983: M K Ali; A U Buzdar; Michael S Ewer; R S Cheng; T P Haynie
Noninvasive cardiac evaluation of patients receiving adriamycin-containing adjuvant chemotherapy (FAC) for stage II or III breast cancer.
Journal of surgical oncology 1983;23(3):212-6.
1983: C Dixon; M K Ali; M R Atallah; Michael S Ewer
Postresection bronchopleural fistula: detection by regional ventilation-perfusion studies.
Southern medical journal 1983;76(4):485-6.
1982: Sewa S Legha; R S Benjamin; B Mackay; H Y Yap; S Wallace; Michael S Ewer; G R Blumenschein; E J Freireich
Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancer.
Cancer 1982;49(9):1762-6.
1982: Michael S Ewer; M K Ali; O H Frazier
Open chest resuscitation for cardiopulmonary arrest related to mechanical impairment of circulation: a report of two cases.
Critical care medicine 1982;10(3):198-9.
1982: Sewa S Legha; Y M Wang; B Mackay; Michael S Ewer; G N Hortobagyi; R S Benjamin; M K Ali
Clinical and pharmacologic investigation of the effects of alpha-tocopherol on adriamycin cardiotoxicity.
Annals of the New York Academy of Sciences 1982;393():411-8.
1980: M K Ali; C F Mountain; Michael S Ewer; D Johnston; T P Haynie
Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma.
Chest 1980;77(3):337-42.